HK1197275A1 - Multigene prognostic assay for lung cancer - Google Patents

Multigene prognostic assay for lung cancer

Info

Publication number
HK1197275A1
HK1197275A1 HK14110835A HK14110835A HK1197275A1 HK 1197275 A1 HK1197275 A1 HK 1197275A1 HK 14110835 A HK14110835 A HK 14110835A HK 14110835 A HK14110835 A HK 14110835A HK 1197275 A1 HK1197275 A1 HK 1197275A1
Authority
HK
Hong Kong
Prior art keywords
lung cancer
prognostic assay
multigene
multigene prognostic
assay
Prior art date
Application number
HK14110835A
Other languages
English (en)
Chinese (zh)
Inventor
David M Jablons
Dan J Raz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1197275A1 publication Critical patent/HK1197275A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK14110835A 2007-06-01 2014-10-29 Multigene prognostic assay for lung cancer HK1197275A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94155007P 2007-06-01 2007-06-01

Publications (1)

Publication Number Publication Date
HK1197275A1 true HK1197275A1 (en) 2015-01-09

Family

ID=40094144

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14110835A HK1197275A1 (en) 2007-06-01 2014-10-29 Multigene prognostic assay for lung cancer

Country Status (10)

Country Link
US (5) US20100240035A1 (fr)
EP (2) EP2082065B1 (fr)
JP (3) JP2010528623A (fr)
CN (2) CN103834729B (fr)
AU (1) AU2008259930B2 (fr)
CA (1) CA2688477C (fr)
HK (1) HK1197275A1 (fr)
IL (1) IL202371A (fr)
NZ (2) NZ599214A (fr)
WO (1) WO2008151072A1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7219016B2 (en) 2001-04-20 2007-05-15 Yale University Systems and methods for automated analysis of cells and tissues
JP5048757B2 (ja) 2006-05-05 2012-10-17 イェール・ユニバーシティー 診断指標または予測指標としての細胞内局在プロフィールの使用
US20090155767A1 (en) * 2007-06-29 2009-06-18 Rimm David L Methods for a predictive diagnostic test for tamoxifen
AU2010203542B2 (en) * 2009-01-07 2017-02-23 Myriad Genetics, Inc Cancer biomarkers
US20120041274A1 (en) 2010-01-07 2012-02-16 Myriad Genetics, Incorporated Cancer biomarkers
US9279157B2 (en) * 2009-02-06 2016-03-08 The Regents Of The University Of California EMX2 in cancer diagnosis and prognosis
WO2010099923A1 (fr) * 2009-03-04 2010-09-10 Roche Diagnostics Gmbh Serpine b 13 en tant que marqueur du carcinome épidermoïde du poumon
EP3812469A1 (fr) 2010-07-07 2021-04-28 Myriad Genetics, Inc. Signatures géniques pour le pronostic du cancer
TW201302793A (zh) 2010-09-03 2013-01-16 Glaxo Group Ltd 新穎之抗原結合蛋白
CN102146461B (zh) * 2011-01-27 2013-02-27 苏州大学 一种检测tp53基因点突变方法及其试剂盒
WO2012116122A2 (fr) * 2011-02-22 2012-08-30 Yale University Classificateur basé sur l'expression protéique, dans la prédiction de la récurrence d'un adénocarcinome
HUE036585T2 (hu) * 2011-07-01 2018-07-30 Univ California Sokgénes prognosztizáló ASSAY tüdõrákra
EP2920322B1 (fr) 2012-11-16 2023-01-11 Myriad Genetics, Inc. Signatures génétiques utilisées en vue du pronostic d'un cancer
CN103344643A (zh) * 2013-07-05 2013-10-09 深圳普门科技有限公司 采用比浊法测量特定蛋白的半自动体外检测设备及方法
CN103344642A (zh) * 2013-07-05 2013-10-09 深圳普门科技有限公司 采用比浊法测量特定蛋白的全自动体外检测设备及方法
CN103335983A (zh) * 2013-07-05 2013-10-02 深圳普门科技有限公司 采用比浊法测量特定蛋白的准自动体外检测设备及方法
EP3623482A1 (fr) 2014-05-13 2020-03-18 Myriad Genetics, Inc. Signatures geniques pour le pronostic du cancer
US11594310B1 (en) 2016-03-31 2023-02-28 OM1, Inc. Health care information system providing additional data fields in patient data
CN105954517B (zh) * 2016-06-30 2018-09-18 四川大学华西医院 一种肺癌筛查试剂盒
CN106119405B (zh) * 2016-08-31 2019-11-12 广州万德基因医学科技有限公司 一种肺癌的预后标记物、使用该标记预测肺癌预后的方法及应用
WO2018174860A1 (fr) * 2017-03-21 2018-09-27 Mprobe Inc. Méthodes et compositions de détection d'un adénocarcinome pulmonaire à un stade précoce par profilage d'expression par arn-seq
CN107881234B (zh) * 2017-11-09 2021-05-04 南京卡迪睿伯生物技术有限公司 一组肺腺癌相关基因标签及其应用
US11967428B1 (en) * 2018-04-17 2024-04-23 OM1, Inc. Applying predictive models to data representing a history of events
EP3899531A4 (fr) * 2018-12-21 2022-11-09 Biomark Cancer Systems Inc. Méthode de détection du cancer du poumon
US11862346B1 (en) 2018-12-22 2024-01-02 OM1, Inc. Identification of patient sub-cohorts and corresponding quantitative definitions of subtypes as a classification system for medical conditions
CN110093422A (zh) * 2019-05-24 2019-08-06 中国人民解放军西部战区总医院 Linc02159在肺腺癌诊疗中的应用
CN110794138A (zh) * 2019-12-06 2020-02-14 四川大学华西医院 Kras自身抗体检测试剂在制备肺癌筛查试剂盒中的用途
CN111154884A (zh) * 2020-03-12 2020-05-15 华东医院 一种肺腺癌预后预测的标志物及其应用
CN112349421A (zh) * 2020-10-26 2021-02-09 中国医学科学院肿瘤医院 一种肺癌患者的治疗预后评估模型
CN118056022A (zh) * 2021-10-09 2024-05-17 鸠江区正江百货经营部 一种基于dna甲基化的肺腺癌预后评估方法
TW202328459A (zh) * 2021-12-20 2023-07-16 大陸商江蘇鵾遠生物技術有限公司 一種腫瘤檢測方法及應用
CN114480644A (zh) * 2022-01-07 2022-05-13 深圳市龙华区人民医院 肺腺癌基于代谢基因的分子分型

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6019944A (en) 1992-05-21 2000-02-01 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US20040170977A1 (en) * 2000-03-31 2004-09-02 Peter Laird Epigenetic sequences for esophageal adenocarcinoma
EP1831684A4 (fr) * 2004-11-30 2009-03-11 Veridex Llc Pronostics de cancer du poumon
AU2006235258A1 (en) * 2005-04-07 2006-10-19 Novartis Vaccines And Diagnostics Inc. Cancer-related genes
CA2612021A1 (fr) * 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions et procedes de traitement et de diagnostic de cancer

Also Published As

Publication number Publication date
US20220195532A1 (en) 2022-06-23
EP2082065A1 (fr) 2009-07-29
CA2688477A1 (fr) 2008-12-11
US20130123130A1 (en) 2013-05-16
US20100240035A1 (en) 2010-09-23
JP2010528623A (ja) 2010-08-26
EP2082065A4 (fr) 2011-01-05
JP2016146822A (ja) 2016-08-18
EP2082065B1 (fr) 2014-03-12
EP2728018A3 (fr) 2014-07-30
CA2688477C (fr) 2020-12-22
CN103834729B (zh) 2016-09-14
AU2008259930B2 (en) 2014-05-29
CN103834729A (zh) 2014-06-04
NZ599214A (en) 2013-12-20
WO2008151072A1 (fr) 2008-12-11
US20200377957A1 (en) 2020-12-03
EP2728018A2 (fr) 2014-05-07
IL202371A (en) 2016-05-31
CN101821405A (zh) 2010-09-01
EP2728018B1 (fr) 2016-11-23
US20180002761A1 (en) 2018-01-04
IL202371A0 (en) 2011-08-01
AU2008259930A1 (en) 2008-12-11
JP5988934B2 (ja) 2016-09-07
NZ581703A (en) 2012-04-27
JP2014012010A (ja) 2014-01-23

Similar Documents

Publication Publication Date Title
HK1197275A1 (en) Multigene prognostic assay for lung cancer
GB0625321D0 (en) Cancer biomarker
HK1204062A1 (en) Lung cancer biomarkers and uses thereof
IL196326A0 (en) Lung cancer diagnostic assay
EP2145185A4 (fr) Dosage de plusieurs analytes
EP2726635A4 (fr) Dosage de pronostic multigénique pour cancer du poumon
IL192794A0 (en) Gene expression markers for colorectal cancer prognosis
EP2021491A4 (fr) Détection de biomarqueurs tumoraux dans le cancer de la bouche
EP1735620A4 (fr) Biomarqueurs de cancer du poumon
HK1189937A1 (en) Distinguishing assay
EP1952157A4 (fr) Dosage de diagnostic du cancer du poumon
EP2095097A4 (fr) Système xrf à source double
EP2231879A4 (fr) Essai de détection de bordetella
EP2046995A4 (fr) Dépistage du cancer par recherche de méthylations de l'adn sérique
EP2220124A4 (fr) Détection de biomarqueurs
EP1907857A4 (fr) Biomarqueurs du cancer du sein
HK1108924A1 (en) Cancer prognostic methods
EP2220506A4 (fr) Biomarqueurs permettant la détection du cancer des ovaires à un stade précoce
EP2210099A4 (fr) Biomarqueurs pour cancer des ovaires
ZA200806316B (en) Gene expression markers for colorectal cancer prognosis
GB0723338D0 (en) Prognostic assay
GB0604231D0 (en) Cancer detection system
GB0724163D0 (en) Syphills detection reagent
GB0722378D0 (en) Prognostic assay
GB0701818D0 (en) Prognostic marker for cancer